Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Will radioiodine be useful in treatment of breast cancer?

Nature Medicine volume 6, pages 859–860 (2000)Cite this article

Expression of a sodium iodide transporter by the thyroid gland causes iodide accumulation, and radioactive iodide is an effective treatment for thyroid cancer. The identification of a similar transporter in mammary tissue indicates that this approach might also be used to treat breast cancer (pages 871–878).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Reduced radioiodine uptake by a papillary thyroid carcinoma, compared to the surrounding normal gland.

References

  1. Marine, D. & Feiss, H.O. The absorption of potassium iodide by perfused thyroid glands and some of the factors modifying it. J. Pharmacol. Exp. Ther. 7, 557–576 (1915).

    CAS  Google Scholar 

  2. Dai, G., Levy, O. & Carrasco, N. Cloning and characterization of the thyroid iodide transporter . Nature 379, 458–460 (1996).

    Article  CAS  Google Scholar 

  3. Tazebay, U.H. et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nature Med. 6, 871 –878 (2000).

    Article  CAS  Google Scholar 

  4. Sawin, C.T. & Becker, D.V. Radioiodine and the treatment of hyperthyroidism: the early history. Thyroid 7, 163–176 (1996).

    Article  Google Scholar 

  5. Mandell, R.B., Mandell, L.Z. & Link, C.J. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res. 59, 661– 668 (1999).

    CAS  PubMed  Google Scholar 

  6. Taurog, A.M. in Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text 8th edn. (eds. Braverman, L.E. & Utiger, R.D.) 61– 85 (Lippincott, Williams & Wilkins, Philadelphia, 2000).

    Google Scholar 

  7. Maxon, H.R. et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N. Engl. J. Med. 309, 937–941 (1983).

    Article  CAS  Google Scholar 

  8. Cobleigh et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic beast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol. 17, 2639–2648 ( 1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School Department of Medicine, Thyroid Unit, Massachusetts General Hospital, Boston, 02115, Massachusetts

    Gilbert H. Daniels

  2. Cancer Center, Massachusetts General Hospital, Boston, 02115, Massachusetts

    Daniel A. Haber

Authors
  1. Gilbert H. Daniels
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel A. Haber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daniels, G., Haber, D. Will radioiodine be useful in treatment of breast cancer?. Nat Med 6, 859–860 (2000). https://doi.org/10.1038/78604

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/78604

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing